Gilead President and CEO John Milligan stepping down
July 25, 2018 at 18:30 PM EDT
Gilead's president and CEO led bold acquisitions that resulted in high-priced drugs, but revenue has slipped and a number of executives have left.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|